2017 American Transplant Congress » Poster Session A: Immunosuppression

5:30pm-7:30pm

Blockade of Tim-3 and PD-1 Reverses Dysfunctions of Tumor Infiltrating Lymphocytes in HBV Related Hepatocellular Carcinoma.

A. Hu, F. Liu, X. Zhu, X. He.

5:30pm-7:30pm

Clinically Relevant Immunosuppression Promotes MCMV Reactivation and Dissemination Following Transplantation of Latently Infected Kidneys.

Z. Zhang,¹ S. Yan,¹ L. Zhao,¹ S. Kurian,² M. Hummel,¹ D. Salomon,² M. Abecassis.¹

5:30pm-7:30pm

D-Dimer Level, in Association with Humoral Responses, Negatively Correlates with Survival of Porcine Islet Grafts in Nonhuman Primates with Immunosuppression.

H. Kang,¹ H. Lee,¹ E. Park,¹ J. Kim,² B. Min,² C.-G. Park.²

5:30pm-7:30pm

Dexamethasone Prolongs Cardiac Allograft Survival in a Murine Model Through Myeloid-Derived Suppressor Cells.

T. Nakao,¹ T. Nakamura,¹ K. Masuda,¹ T. Matsuyama,¹ H. Ushigome,¹ E. Ashihara,² N. Yoshimura.¹

5:30pm-7:30pm

Differential Effects of Immunosuppressive Drugs on DNA Methylation in T Cells.

F. Peters,¹ A. Peeters,¹ L. Hofland,² M. Betjes,¹ K. Boer,¹ C. Baan.¹

5:30pm-7:30pm

Immunosuppressive Ability of NFkB Inhibitor: Withaferin A.

M. Kanak,¹ Y. Shindo,¹ M. Levy,^1,2 B. Naziruddin.³

5:30pm-7:30pm

Immunosuppressive Treatment Alters Gut Microbiota and Modified Gut Microbiota Affects Immune Status.

Z. Zhang, Y. Xu, Q. Zhang, X. Hu.

5:30pm-7:30pm

Kidney-Specific Immunosuppression without Adverse Systemic Effects.

D. Kentrup,¹ K. Schuette-Nuetgen,¹ H. Pawelski,¹ H. Pavenstädt,¹ S. Hermann,² M. Schaefers,² G. Larbig,³ A. Kuebelbeck,³ S. Reuter.¹

5:30pm-7:30pm

Medicinal Herb Cordyceps Sinensis Promotes Long-Term Allograft Survival by Tipping the Balance Between CD4+FoxP3+ Tregs and CD8+ Tcm Cells.

Z. Dai,¹ H. Dai.²

5:30pm-7:30pm

Mycophenolic Acid Needs Ca²⁺ to Exert Its Anti-inflammatory Action via Shedding of Toll-Like Receptor4 and Tumor Necrosis Factor Receptor 1.

J. Kim,¹ W. Yang,¹ C. Baek,¹ N. Han,² S.-K. Park.¹

5:30pm-7:30pm

New Approach for Targeted Immunotherapy in Vascularized Composite Allotransplantation.

F. Feturi,¹ H. Wang,² Y. Brudno,² V. Erbas,³ Z. Zhang,³ H. Sahin,³ D. Mooney,² V. Gorantla,³ R. Venkataramanan.¹

5:30pm-7:30pm

Novel Therapies for Diabetic Kidney Disease.

M. Nguyen, K. Kodama, M. Sarwal.

5:30pm-7:30pm

Short-Term Combination Treatment of FK506 and Anti-CD40 Ligand Remarkably Prolong Allograft Survival Time in Mouse Skin Transplantation.

X. Zhang, Z. Ding, M. Yang, Y. Miao, Y. Yang, P. Zhou.

5:30pm-7:30pm

Tacrolimus Suppresses Calcineurin Activity and Ca2+ Influx Age-Specifically.

F. Krenzien,^1,2 M. Quante,¹ H. Uehara,¹ R. Abdi,¹ H. Cetina Biefer,¹ M. Schmelzle,² J. Pratschke,² A. Elkhal,¹ S. Tullius.¹

5:30pm-7:30pm

Tacrolimus and Mycophenolic Acid Have a Limited Inhibitory Effect on Monocyte Signaling Pathway Phosphorylation, Function and Differentiation.

N. Kannegieter,¹ D. Hesselink,¹ M. Dieterich,¹ R. Kraaijeveld,¹ A. Rowshani,¹ P. Leenen,² C. Baan.¹

5:30pm-7:30pm

Targeting JAK-STAT Pathways with Tofacitinib Provides a Novel Approach for Conditioning in Allogeneic BMT Recipients.

H. Xu, A. Merchak, M. Xu, C. Mort, T. Dowling, L. Kahn, M. Binion, A. Chhabra, Y. Wen, Y. Huang, S. Ildstad.